Defilade Capital Management, L.P.

Defilade Capital Management, L.P. reported 30 holdings worth US$599M as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

Defilade Capital Management, L.P. reported 30 holdings worth US$599M as of Sep 30, 2026. Largest: Pfizer, Inc., Eli Lilly and Company and BioMarin Pharmaceutical Inc. Filed Nov 16, 2026 (Form 13F).

Holdings
30
Value as reported
US$599M

The filing in full

CompanySharesValue as reported% of portfolio
Pfizer, Inc.1.52MUS$43.5M7.3%
Eli Lilly and Company34,774US$40.2M6.7%
BioMarin Pharmaceutical Inc.602KUS$36.1M6.0%
Gilead Sciences, Inc.227KUS$33.8M5.6%
Axsome Therapeutics, Inc.175KUS$32.3M5.4%
Amgen Inc.74,079US$31.2M5.2%
ORIC Pharmaceuticals, Inc.2.27MUS$30.6M5.1%
Intuitive Surgical, Inc.71,860US$29.2M4.9%
Stryker Corporation81,524US$22.5M3.7%
Vera Therapeutics, Inc.652KUS$21.1M3.5%
Cogent Biosciences, Inc.632KUS$20.2M3.4%
Veeva Systems Inc.69,141US$19.7M3.3%
Agios Pharmaceuticals, Inc.570KUS$19M3.2%
Thermo Fisher Scientific Inc26,469US$17.9M3.0%
Ocular Therapeutix, Inc.2.28MUS$17.5M2.9%
Larimar Therapeutics, Inc.4.93MUS$15.8M2.6%
Boston Scientific Corporation351KUS$15.3M2.6%
Revolution Medicines, Inc.71,186US$14.6M2.4%
Solventum Corporation166KUS$14.6M2.4%
Envista Holdings Corporation534KUS$12.5M2.1%
Olema Pharmaceuticals, Inc.1.44MUS$12.4M2.1%
Evommune, Inc.1.43MUS$11.8M2.0%
Eledon Pharmaceuticals, Inc.3.53MUS$8.92M1.5%
ICU Medical, Inc.54,435US$8.74M1.5%
Enovis Corporation400KUS$7.3M1.2%
PACS Group, Inc.165KUS$6.86M1.1%
Black Diamond Therapeutics, Inc.1.77MUS$3.34M0.56%
Mereo BioPharma Group plc7.56MUS$3.04M0.51%
PTC Therapeutics, Inc.0US$00.00%
STAAR Surgical Company0US$00.00%
Teleflex Incorporated0US$00.00%
Tyra Biosciences, Inc.0US$00.00%
Zimmer Biomet Holdings, Inc.0US$00.00%
Abbott Laboratories0US$00.00%
Baxter International Inc.0US$00.00%
Crinetics Pharmaceuticals, Inc.0US$00.00%
Denali Therapeutics Inc.0US$00.00%
Elanco Animal Health Incorporated0US$00.00%
Glaukos Corporation0US$00.00%
Globus Medical, Inc.0US$00.00%
Insmed Incorporated0US$00.00%
Insulet Corporation0US$00.00%
Lantheus Holdings, Inc.0US$00.00%

Source

Download original · View original at SEC

Related